• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高亲和力或低亲和力细胞毒性T淋巴细胞的选择性扩增及其过继性免疫治疗的疗效

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

作者信息

Alexander-Miller M A, Leggatt G R, Berzofsky J A

机构信息

Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1578, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7. doi: 10.1073/pnas.93.9.4102.

DOI:10.1073/pnas.93.9.4102
PMID:8633023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC39494/
Abstract

The conventional approach to cytotoxic T-lymphocyte (CTL) induction uses maximal antigen concentration with the intent of eliciting more CTL. However, the efficacy of this approach has not been systematically explored with regard to the quality of the CTLs elicited or their in vivo functionality. Here, we show that a diametrically opposite approach elicits CTLs that are much more effective at clearing virus. CTLs specific for a defined peptide epitope were selectively expanded with various concentrations of peptide antigen. CTLs generated with exceedingly low-dose peptide lysed targets sensitized with > 100-fold less peptide than CTLs generated with high-dose peptide. Differences in expression of T-cell antigen receptors or a number of other accessory molecules did not account for the functional differences. Further, high-avidity CTLs adoptively transferred into severe combined immunodeficient mice were 100- to 1000-fold more effective at viral clearance than the low-avidity CTLs, despite the fact that all CTL lines lysed virus-infected targets in vitro. Thus, the quality of CTLs is as important as the quantity of CTLs for adoptive immunotherapy, and the ability to kill virally infected targets in vitro is not predictive of in vivo efficacy, whereas the determinant density requirement described here is predictive. Application of these principles may be critical in developing effective adoptive cellular immunotherapy for viral infections and cancer.

摘要

传统的细胞毒性T淋巴细胞(CTL)诱导方法使用最大抗原浓度,旨在引发更多的CTL。然而,就所引发的CTL的质量或其体内功能而言,这种方法的有效性尚未得到系统的探索。在此,我们表明一种截然不同的方法能引发在清除病毒方面更有效的CTL。针对特定肽表位的CTL用不同浓度的肽抗原进行选择性扩增。用极低剂量肽产生的CTL裂解用比高剂量肽产生的CTL少100倍以上肽致敏的靶细胞。T细胞抗原受体或许多其他辅助分子表达的差异并不能解释功能上的差异。此外,尽管所有CTL系在体外都能裂解病毒感染的靶细胞,但将高亲和力的CTL过继转移到严重联合免疫缺陷小鼠体内,在病毒清除方面比低亲和力的CTL有效100至1000倍。因此,对于过继免疫疗法而言,CTL的质量与CTL的数量同样重要,并且在体外杀死病毒感染靶细胞的能力并不能预测体内疗效,而此处描述的决定簇密度要求是可以预测的。这些原则的应用对于开发针对病毒感染和癌症的有效过继细胞免疫疗法可能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d778/39494/726d0993c686/pnas01516-0400-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d778/39494/726d0993c686/pnas01516-0400-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d778/39494/726d0993c686/pnas01516-0400-a.jpg

相似文献

1
Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.高亲和力或低亲和力细胞毒性T淋巴细胞的选择性扩增及其过继性免疫治疗的疗效
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7. doi: 10.1073/pnas.93.9.4102.
2
Molecular mechanisms and biological significance of CTL avidity.细胞毒性T淋巴细胞亲和力的分子机制及生物学意义
Curr HIV Res. 2003 Jul;1(3):287-94. doi: 10.2174/1570162033485230.
3
Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes.无反应性的诱导限制了通过过继转移的MDM2特异性细胞毒性T淋巴细胞对肿瘤的保护作用。
Cancer Res. 2004 Nov 1;64(21):8052-6. doi: 10.1158/0008-5472.CAN-04-0630.
4
Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.针对人癌胚抗原免疫显性表位的细胞毒性T细胞系的表型稳定性
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2439-49.
5
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.在严重联合免疫缺陷(SCID)小鼠异种移植模型中,过继转移的人肺肿瘤特异性细胞毒性T细胞可以控制自体肿瘤生长并塑造肿瘤表型。
J Transl Med. 2007 Jun 25;5:29. doi: 10.1186/1479-5876-5-29.
6
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.岩藻糖化增强过继转移的抗原特异性细胞毒性 T 淋巴细胞的疗效。
Clin Cancer Res. 2019 Apr 15;25(8):2610-2620. doi: 10.1158/1078-0432.CCR-18-1527. Epub 2019 Jan 15.
7
Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.携带甲胎蛋白特异性T细胞受体基因的工程化细胞毒性T淋巴细胞用于肝细胞癌的过继性免疫治疗
Tumour Biol. 2016 Jan;37(1):799-806. doi: 10.1007/s13277-015-3845-9. Epub 2015 Aug 7.
8
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.使用唑来膦酸进行过继免疫治疗以大规模扩增 γδ T 细胞和肽特异性细胞毒性 T 细胞。
Int J Oncol. 2014 Nov;45(5):1847-56. doi: 10.3892/ijo.2014.2634. Epub 2014 Sep 3.
9
The ability of peptides to induce cytotoxic T cells in vitro does not strongly correlate with their affinity for the H-2Ld molecule: implications for vaccine design and immunotherapy.肽在体外诱导细胞毒性T细胞的能力与其对H-2Ld分子的亲和力并不密切相关:对疫苗设计和免疫治疗的启示。
Mol Immunol. 1997 Feb;34(3):273-81. doi: 10.1016/s0161-5890(97)00019-9.
10
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.使用荧光组织相容性白细胞抗原-A*0201/人乳头瘤病毒16型E7肽复合物分离识别内源性人乳头瘤病毒抗原的罕见人类细胞毒性T淋巴细胞。
Cancer Res. 2000 Jan 15;60(2):365-71.

引用本文的文献

1
The frequency and function of nucleoprotein-specific CD8 T cells are critical for heterosubtypic immunity against influenza virus infection.核蛋白特异性 CD8 T 细胞的频率和功能对于针对流感病毒感染的异源免疫至关重要。
J Virol. 2024 Aug 20;98(8):e0071124. doi: 10.1128/jvi.00711-24. Epub 2024 Jul 31.
2
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.肿瘤浸润淋巴细胞的新抗原特异性刺激可实现有效的 TCR 分离和扩增,同时保持干细胞样记忆表型。
J Immunother Cancer. 2024 May 30;12(5):e008645. doi: 10.1136/jitc-2023-008645.
3

本文引用的文献

1
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.体外诱导人细胞毒性T淋巴细胞对突变型和野生型p53肽段的反应。
Eur J Immunol. 1993 Sep;23(9):2072-7. doi: 10.1002/eji.1830230905.
2
Is CD8 dependence a true reflection of TCR affinity for antigen?CD8依赖性是否真正反映了T细胞受体对抗原的亲和力?
Int Immunol. 1993 Oct;5(10):1219-28. doi: 10.1093/intimm/5.10.1219.
3
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice.
编码分泌型非稳定 Spike 的 SARS-CoV-2 mRNA 疫苗在雌性小鼠中的免疫原性和保护效力。
Nat Commun. 2023 Apr 21;14(1):2309. doi: 10.1038/s41467-023-37795-0.
4
Influenza-Induced CD103 T Resident Memory Cells Exhibit Enhanced Functional Avidity over CD103 Memory T Cells in the Mediastinal Lymph Node.流感诱导的 CD103 T 驻留记忆细胞在纵隔淋巴结中表现出比 CD103 记忆 T 细胞更高的功能亲和力。
Immunohorizons. 2022 Oct 11;6(10):705-715. doi: 10.4049/immunohorizons.2100074.
5
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.通过逐步增加肽-HLA 与 TCR 的亲和力来探索 CD8 T 细胞的功能和交叉反应性。
Front Immunol. 2022 Aug 10;13:973986. doi: 10.3389/fimmu.2022.973986. eCollection 2022.
6
Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions.癌症疫苗领域的变化——新型蛋白质组学平台用于新型抗原组成。
Int J Mol Sci. 2022 Apr 15;23(8):4401. doi: 10.3390/ijms23084401.
7
N-of-1 Healthcare: Challenges and Prospects for the Future of Personalized Medicine.单病例医疗:个性化医疗未来的挑战与前景
Front Digit Health. 2022 Feb 11;4:830656. doi: 10.3389/fdgth.2022.830656. eCollection 2022.
8
Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance.嵌合抗原受体(CAR)和 T 细胞受体(TCR)转基因 T 细胞过继细胞疗法治疗多发性骨髓瘤:反应和耐药性。
Cells. 2022 Jan 25;11(3):410. doi: 10.3390/cells11030410.
9
Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses.肿瘤 MHC Ⅱ类肽洗脱鉴定的瓜氨酸化表位可刺激调节性和 Th1 反应,需要仔细选择以获得最佳的抗肿瘤反应。
Front Immunol. 2021 Nov 9;12:764462. doi: 10.3389/fimmu.2021.764462. eCollection 2021.
10
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1 tumor-specific peptide.表达针对 HLA-A2 限制性 NY-ESO-1 肿瘤特异性肽的人 TCR 1G4 的 HLA-A2 转基因小鼠的构建与鉴定。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002544.
编码一种被浸润肿瘤的自体T细胞识别的共享人类黑色素瘤抗原的基因的克隆。
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3515-9. doi: 10.1073/pnas.91.9.3515.
4
Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.细胞毒性T细胞对HIV-1 gp160的两个表位具有交叉反应性且在I类主要组织相容性复合体限制方面存在简并性,这些细胞毒性T细胞优先使用Vβ。
J Immunol. 1993 Aug 15;151(4):2283-95.
5
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.将HIV-1特异性细胞毒性T淋巴细胞转移至一名艾滋病患者体内会导致对HIV突变体的选择以及随后的疾病进展。
Nat Med. 1995 Apr;1(4):330-6. doi: 10.1038/nm0495-330.
6
Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.对同时功能性结合I类和II类主要组织相容性复合体分子的相同HIV肽进行分子分析。
J Immunol. 1995 Feb 15;154(4):1973-86.
7
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.针对淋巴细胞性脉络丛脑膜炎病毒的克隆化细胞毒性T淋巴细胞的生物学特性:病毒在体内的清除
J Virol. 1984 Sep;51(3):682-6. doi: 10.1128/JVI.51.3.682-686.1984.
8
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.扩增用于免疫治疗试验的人肿瘤浸润淋巴细胞。
J Immunol Methods. 1987 Aug 24;102(1):127-41. doi: 10.1016/s0022-1759(87)80018-2.
9
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.肿瘤浸润淋巴细胞和白细胞介素-2在转移性黑色素瘤患者免疫治疗中的应用。初步报告。
N Engl J Med. 1988 Dec 22;319(25):1676-80. doi: 10.1056/NEJM198812223192527.
10
Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.H-2 限制性细胞毒性 T 淋巴细胞的抗原识别:抗 CD8 单克隆抗体对细胞溶解的抑制作用取决于肽抗原的浓度和一级序列。
Eur J Immunol. 1988 Nov;18(11):1863-6. doi: 10.1002/eji.1830181135.